| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2824139 | Plasmid | 2014 | 11 Pages |
•Lycopene is an effective antioxidant for treatment for some cancers and degenerative human conditions.•Study aims at generating a yeast strain with high lycopene productivity by expressing crt-genes derived from E. uredovora.•The highest production of lycopene was 3280 μg/g dry cell weight, which is higher than the previously reported levels.•The study reveals that pathways for lycopene and ergosterol syntheses compete for the use of farnesyl diphosphate.
Lycopene is an effective antioxidant proposed as a possible treatment for some cancers and other degenerative human conditions. This study aims at generation of a yeast strain (Saccharomyces cerevisiae) of efficient productivity of lycopene by overexpressing synthetic genes derived from crtE, crtB and crtI genes of Erwinia uredovora. These synthetic genes were constructed in accordance with the preferred codon usage in S. cerevisiae but with no changes in amino acid sequences of the gene products. S. cerevisiae cells were transformed with these synthetic crt genes, whose expression was regulated by the ADH2 promoter, which is de-repressed upon glucose depletion. The RT-PCR and Western blotting analyses indicated that the synthetic crt genes were efficiently transcribed and translated in crt-transformed S. cerevisiae cells. The highest level of lycopene in one of the transformed lines was 3.3 mg lycopene/g dry cell weight, which is higher than the previously reported levels of lycopene in other microorganisms transformed with the three genes. These results suggest the excellence of using the synthetic crt genes and the ADH2 promoter in generation of recombinant S. cerevisiae that produces a high level of lycopene. The level of ergosterol was reversely correlated to that of lycopene in crt-transformed S. cerevisiae cells, suggesting that two pathways for lycopene and ergosterol syntheses compete for the use of farnesyl diphosphate.
